Naptumomab estafenatox

Naptumomab estafenatox
Schematic image of naptumomab estafenatox.

VH, VL: variable (antigen binding) domains of antibody fragment
CH1, CL: constant domains of antibody fragment

SAg: superantigen SEA/E-120
Monoclonal antibody
TypeFab fragment
SourceMouse
Target5T4
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC3255H5025N855O1050S18
Molar mass73513.02 g·mol−1
 NY (what is this?)  (verify)

Naptumomab estafenatox (ABR-217620) is a drug being developed for the treatment of various types of cancer like non-small cell lung carcinoma and renal cell carcinoma.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.